Neurosurgical and Neuroendovascular Management of Takayasu's Arteritis

医学 动脉炎 外科 血运重建 灌注 血管内治疗 大动脉炎 放射科 大动脉炎 锁骨下动脉 血管炎 心脏病学 内科学 动脉瘤 疾病 心肌梗塞
作者
Marcus A. Stoodley,Reid C. Thompson,R. Scott Mitchell,Michael P. Marks,Gary K. Steinberg
出处
期刊:Neurosurgery [Oxford University Press]
卷期号:46 (4): 841-852 被引量:5
标识
DOI:10.1097/00006123-200004000-00014
摘要

The roles of surgical and endovascular treatments for patients with Takayasu's arteritis are not clear. We report our experience in the neurosurgical and/or neuroendovascular treatment of patients with Takayasu's arteritis who exhibited ischemic neurological symptoms.Between 1994 and 1998, seven patients with Takayasu's arteritis and neurological symptoms were treated at the Stanford University Medical Center. All patients were angiographically evaluated and received maximal medical therapy. Cerebral blood flow studies were performed for six patients. Three patients underwent surgical revascularization procedures alone, two underwent combinations of surgical and endovascular procedures, and two underwent endovascular treatment alone.The most common neurological symptoms were dysequilibrium, syncope, and visual disturbances. The characteristic angiographic features of Takayasu's arteritis were identified for all patients. The subclavian arteries and proximal carotid and vertebral arteries were involved in all patients. Two patients exhibited improvement of their symptoms after endovascular treatment alone. There were two deaths after surgery, involving patients with severe global cerebral hypoperfusion. All other surgically treated patients exhibited improvement of their symptoms, with patent grafts, up to 4 years after surgery. Cerebral blood flow improved after treatment.Improvement of symptoms can be achieved with surgical revascularization and/or endovascular treatment. Staged revascularization might be better than one-stage bilateral high-flow grafting for patients with severe global hypoperfusion.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
GreyRat完成签到 ,获得积分10
2秒前
知秋完成签到 ,获得积分10
4秒前
无极2023完成签到 ,获得积分0
8秒前
nav完成签到 ,获得积分10
10秒前
11秒前
2316690509完成签到 ,获得积分10
16秒前
日暮炊烟完成签到 ,获得积分10
18秒前
青葱鱼块完成签到 ,获得积分10
20秒前
22秒前
Ava应助shan采纳,获得10
22秒前
胡茶茶完成签到 ,获得积分10
24秒前
28秒前
31秒前
汉堡国王发布了新的文献求助10
32秒前
xu完成签到 ,获得积分10
33秒前
满集完成签到 ,获得积分10
33秒前
shan发布了新的文献求助10
34秒前
会写日记的乌龟先生完成签到,获得积分10
39秒前
Yang完成签到 ,获得积分10
40秒前
victory_liu完成签到,获得积分10
42秒前
共享精神应助阿华采纳,获得10
43秒前
大个应助shan采纳,获得10
57秒前
风中的修杰完成签到 ,获得积分10
1分钟前
渊_完成签到 ,获得积分10
1分钟前
Ha完成签到,获得积分10
1分钟前
1分钟前
笑笑完成签到 ,获得积分10
1分钟前
shan发布了新的文献求助10
1分钟前
onevip完成签到,获得积分0
1分钟前
1分钟前
月亮啊完成签到 ,获得积分10
1分钟前
1分钟前
shan发布了新的文献求助10
1分钟前
ChatGPT完成签到,获得积分10
1分钟前
健壮惋清发布了新的文献求助10
1分钟前
红毛兔完成签到,获得积分10
1分钟前
霸气皓轩应助poki采纳,获得10
1分钟前
派大星和海绵宝宝完成签到,获得积分10
1分钟前
roundtree完成签到 ,获得积分0
1分钟前
mark33442完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Social Cognition: Understanding People and Events 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6028402
求助须知:如何正确求助?哪些是违规求助? 7690218
关于积分的说明 16186463
捐赠科研通 5175575
什么是DOI,文献DOI怎么找? 2769577
邀请新用户注册赠送积分活动 1753048
关于科研通互助平台的介绍 1638819